Biotransformation of natural compounds. Oxido-reduction of Sch-642305 by Aspergillus ochraceus ATCC 1009

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 8, 2011, Pages 2456-2459

  Adelin, Emilie ^a   Servy, Claudine ^a   Cortial, Sylvie ^a   Lévaique, Hélne ^a   Gallard, Jean Franois ^a   Martin, Marie Thérse ^a   Retailleau, Pascal ^a   Bussaban, Boonsom ^b   Lumyong, Saisamorn ^b   Ouazzani, Jamal ^a  

^a INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Aspergillus ochraceus; Biotransformation; Chemodiversity; Hydroxyltion; Sch 642305

Indexed keywords

CARBONYL DERIVATIVE; NATURAL PRODUCT; SCH 642305; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS OCHRACEUS; CANCER CELL CULTURE; CHEMICAL BOND; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; DRUG TRANSFORMATION; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; HYDROXYLATION; IC 50; NUCLEAR OVERHAUSER EFFECT; OXIDATION REDUCTION REACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-BACTERIAL AGENTS; ASPERGILLUS OCHRACEUS; BIOTRANSFORMATION; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; HUMANS; KINETICS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION; OXIDATION-REDUCTION;

ASPERGILLUS OCHRACEUS; FUNGI; NEGIBACTERIA; PHOMOPSIS;

EID: 79953278003     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.02.063     Document Type: Article

References (25)

1. A.L. Harvey Drug Discovery Today 13 2008 894
2. J.S. Lazo, and P. Wipf J. Pharmacol. Exp. Ther. 293 2000 705
3. B.R. Stockwell Nature 432 2004 846
4. S.G. Van Lanen, and B. Shen Curr. Opin. Microbiol. 9 2006 252
5. D. Bol, and R. Ebner Pharmacogenomics 7 2006 227
6. J.H. Liu, and B.Y. Yu Curr. Org. Chem. 14 2010 1400
7. Y. Asakawa, and Y. Noma Comprehensive Nat. Prod. II Chem. Biol. 3 2010 803
8. Y. Asakawa, and Y. Noma Comprehensive Nat. Prod. II Chem. Biol. 3 2010 893
9. Y. Noma, and Y. Asakawa Comprehensive Nat. Prod. II Chem. Biol. 3 2010 669
10. A. Decor, D. Bellocq, O. Thoison, N. Lekieffre, A. Chiaroni, J. Ouazzani, T. Cresteil, F. Gueritte, and O. Baudoin Bioorg. Med. Chem. 14 2006 1558
11. A. Leverrier, M.T. Martin, C. Servy, J. Ouazzani, P. Retailleau, K. Awang, M.R. Mukhtar, F. Gueritte, and M. Litaudon J. Nat. Prod. 73 2010 1121
12. M. Chu, R. Mierzwa, L. Xu, L. He, J. Terracciano, M. Patel, V. Gullo, T. Black, W. Zhao, T.M. Chan, and A.T. McPhail J. Nat. Prod. 66 2003 1527
13. Five liter of Potato Dextrose Broth PDB (Difco) were inoculated with Phomopsis sp. CMU-LMA spores and cultivated at 27 °C and 200 rpm for five days. The medium was extracted with 3 × 1 L of ethyl acetate. The organic layers were evaporated under reduced pressure affording 1.9 g of whole extract. Compound was purified by silica gel chromatography using a Combiflash Companion Chromatograph and a ready-to-use RediSep column (80 g, 35-70 μm mesh). The solvent consisted of a mixture of ethyl acetate/heptane, 30-70% for 45 min, then 50-50% for 45 min. This procedure afforded 325 mg of pure Sch-642305.
14. B. Bussaban, S. Lumyong, P. Lumyong, T. Seelanan, D.C. Park, E.H. McKenzie, and K.D. Hyde Mycologia 97 2005 1002
15. 5Na 293.1365).
16. 2. After extensive software and calculation refinements the compound assumed 100% enantiopure as (4S,8aR,12S,12aR)-12-hydroxy-4-methyldecahydro-1H-benzo[d]oxecine-2,9-dione. Crystallographic data for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre under the respective following deposit number CCDC-786076 for Sch-642305 and CCDC- 805294 for compound 1. Copies of these data can be obtained, free of charge on application to the Director, CCDC 12 Union Road, Cambridge CB2 1EZ, UK (fax: (+44) 1223 336033; or e-mail: deposit@ccdc.cam.uk ).
17. S. Arseniyadis, R. Rodriguez, M.M. Dorado, R.B. Alves, J. Ouazzani, and G. Ourisson Tetrahedron 50 1994 8399
18. J. Ouazzani, S. Arséniyadis, R. Alvarez-Manzaneda, A. Rumbero, and G. Ourisson Tetrahedron Lett. 32 1991 1983
19. D. Herlem, J. Ouazzani, and F. Khuong-Huu Tetrahedron Lett. 37 1996 1241
20. 4. The microorganisms were allowed to grow at 27 °C in rotary shaker mixtures (200 rpm). After three days, the biomass was recovered by filtration, washed twice with water, compacted and then added directly to water containing a suspension of the substrate Sch-642305. In a typical analytical incubation, 5 g of wet biomass was introduced into a 30 mL aqueous suspension of 10 mg of Sch-642305 in a 200 mL Erlenmeyer flask with or without 10% glucose.
21. -1. Three pure fractions were recovered consisting of 29.6 mg of 1, 33.5 mg of 2 and 35.3 mg of 3 and 46 mg of a mixed fraction.
22. C. Tempete, G.H. Werner, F. Favre, A. Rojas, and N. Langlois Eur. J. Med. Chem. 30 1995 647
23. V. Perri, C. Rochais, J.S.D. Santos, R. Legay, T. Cresteil, P. Dallemagne, and S. Rault Eur. J. Med. Chem. 45 2010 1146
24. H.L. Holland, and H.K. Weber Curr. Opin. Biotechnol. 11 2000 547
25. 50 determination experiments were performed in duplicate.